CIZ1 Antibodies

Santa Cruz Biotechnology features a diverse variety of CIZ1 monoclonal antibodies for research focused on understanding CIZ1's role in cellular processes. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CIZ1, or Cdk2-interacting zinc finger protein 1, plays a crucial role in cell cycle regulation and DNA replication. CIZ1 coordinates cellular responses to DNA damage and maintains genomic stability. Research has shown that CIZ1 expression levels are altered in various cancer types, making it an important focus for understanding disease mechanisms. CIZ1's involvement in cell cycle control and DNA replication initiation suggests potential therapeutic applications in cancer treatment. Investigating CIZ1's molecular interactions and regulatory pathways can provide insights into cellular proliferation and genome maintenance. Understanding CIZ1's function in normal and pathological conditions may lead to new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CIZ1's role in human health and disease.